CAROL HARRINGTON: Open Payments
NPI 1124018437 · INDEPENDENCE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,392 in 14 payments from 11 companies in 2025. Trend: 2023 $652 · 2024 $1,376 · 2025 $1,392
Food & beverage: $1,392
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $247 |
| Abbott Laboratories | 2 | $171 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Averitas Pharma Inc. | 1 | $125 |
| Lundbeck LLC | 2 | $124 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| Novo Nordisk Inc | 1 | $112 |
| Edwards Lifesciences Corporation | 1 | $108 |
| Otsuka America Pharmaceutical, Inc. | 1 | $107 |
| Amgen Inc. | 1 | $80 |
Products named: REXULTI, FREESTYLE LIBRE 3, AIRSUPRA, QUTENZA, UZEDY, AUSTEDO XR, Auvelity, Ozempic.
Industry payments across MO — which companies pay providers there.
